1. P033 Mcl-1 confers protection of breast cancer cells exposed to hypoxia: therapeutic implications. (March 2015) Authors: Bashari, M.H.; Fan, F.; Arn, M.; Vallet, S.; Opferman, J.; Cardone, M.H.; Schneeweiss, A.; Jäger, D.; Podar, K. Journal: Breast Issue: Volume 24(2015)Supplement 1 Page Start: S37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. S179: RANDOMIZED COMPARISON BETWEEN KRD AND KTD INDUCTION, FOLLOWED BY K MAINTENANCE OR OBSERVATION IN TRANSPLANT NON-ELIGIBLE PATIENTS WITH NDMM (AGMT-MM02 TRIAL). (23rd June 2022) Authors: Ludwig, H.; Melchardt, T.; Sormann, S.; Zojer, N.; Andel, J.; Hartmann, B.; Tinchon, C.; Gunsilius, E.; Podar, K.; Egle, A.; Willenbacher, W.; Wöll, E.; Schreder, M.; Ruckser, R.; Bozic, B; Krauth, M.-T.; Petzer, A.; Schmitt, C; Machherndl-Spandl, S.; Agis, H. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 80 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗